Prime presents at HLTH USA conference on Oct. 20 - Prime Therapeutics
Prime presents at HLTH USA conference on Oct. 20
Dinesh Kandanchatha, chief information and technology officer at Prime Therapeutics, will join Andy Fanning, CEO of Optura, for a discussion about momentum of artificial intelligence (AI) in health care
The annual HLTH USA health care innovation conference, this year held in Las Vegas, from Oct. 19–22, gathers more than 12,000 attendees from across the health ecosystem, including providers, payers, pharma, startups, investors, employers, government and consumer tech. Featuring more than 400 speakers and over 900 sponsors, the event showcases cutting-edge topics such as artificial intelligence (AI) in health care, value-based care, health equity, drug development, chronic condition management and more.
At an Oct. 20 session, Dinesh Kandanchatha, chief information and technology officer at Prime Therapeutics (Prime), and Andy Fanning, chief executive officer at Optura, will share how they built an AI Center of Excellence using the Optura platform to meet the evolving needs of AI in health care.
Event
Panel
“How Prime Therapeutics Built an AI Engine That Turns Ideas into Action”
Date/time
Monday, Oct. 20, 2025, 3:05–3:25 p.m. PT
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.